Marijuana meets criteria for reclassification as lower-risk drug, FDA scientific review finds | CNN
www.cnn.com
Marijuana has a lower potential for abuse than other drugs that are subjected to the same restrictions, with some scientific support for its use as a medical treatment, researchers from the US Food and Drug Administration say in documents supporting its reclassification as a Schedule III substance.

Marijuana has a lower potential for abuse than other drugs that are subjected to the same restrictions, with scientific support for its use as a medical treatment, researchers from the US Food and Drug Administration say in documents supporting its reclassification as a Schedule III substance.

Marijuana is currently classified as Schedule I, reserved for the most dangerous controlled substances, including heroin and LSD. In 2022, President Joe Biden asked US Health and Human Services Secretary Xavier Becerra and the attorney general to begin the administrative process of reviewing how marijuana is scheduled under federal law. HHS Assistant Secretary for Health Adm. Rachel Levine wrote a letter to the Drug Enforcement Administration in August in which she supported the reclassification to Schedule III, a list that includes “drugs with a moderate to low potential for physical and psychological dependence” such as ketamine, testosterone and Tylenol with codeine.

…

Rescheduling marijuana could open up more avenues for research, allow cannabis businesses to bank more freely and openly, and have firms no longer subject to a 40-year-old tax code that disallows credits and deductions from income generated by sales of Schedule I and II substances.

  • stinky613@lemmy.sdf.orgEnglish
    733·
    10 months ago

    It’s inherently problematic that the DEA is in charge of scheduling

    Rescheduling marijuana would likely lead to a lower budget for the DEA… No way is the DEA going to voluntarily lower the scheduling of such a widely used drug

    • Habahnow@sh.itjust.works
      617·
      10 months ago

      They don’t get money based on how many drugs are illegal. Not to mention, they like to go after big dealers which some will continue to import illegally or grow it in illegal ways. The DEA will still come after them.

      • stinky613@lemmy.sdf.orgEnglish
        1·
        9 months ago

        They get money based on the resources needed to tackle illegal drug manufacturing/sales/usage

        The more widely used an illegal drug is, the more resources they need to fight it